Roffman Miller Associates Inc Pa buys $15,684,961 stake in Stryker Corporation (SYK)

Stryker Corporation (SYK) : Roffman Miller Associates Inc Pa scooped up 615 additional shares in Stryker Corporation during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Jul 19, 2016. The investment management firm now holds a total of 128,187 shares of Stryker Corporation which is valued at $15,684,961.Stryker Corporation makes up approximately 2.50% of Roffman Miller Associates Inc Pa’s portfolio.

Other Hedge Funds, Including , Pennsylvania Trust Co boosted its stake in SYK in the latest quarter, The investment management firm added 405 additional shares and now holds a total of 13,371 shares of Stryker Corporation which is valued at $1,636,076. Stryker Corporation makes up approx 0.13% of Pennsylvania Trust Co’s portfolio.Stewart Patten Co reduced its stake in SYK by selling 2,011 shares or 1.68% in the most recent quarter. The Hedge Fund company now holds 117,797 shares of SYK which is valued at $14,413,641. Stryker Corporation makes up approx 2.75% of Stewart Patten Co’s portfolio.Gulf International Bank (uk) Ltd reduced its stake in SYK by selling 200 shares or 0.2% in the most recent quarter. The Hedge Fund company now holds 100,546 shares of SYK which is valued at $12,317,890. Stryker Corporation makes up approx 0.20% of Gulf International Bank (uk) Ltd’s portfolio.Perkins Coie Trust Co boosted its stake in SYK in the latest quarter, The investment management firm added 451 additional shares and now holds a total of 20,761 shares of Stryker Corporation which is valued at $2,538,863. Stryker Corporation makes up approx 1.65% of Perkins Coie Trust Co’s portfolio.

Stryker Corporation opened for trading at $122.3 and hit $122.65 on the upside on Wednesday, eventually ending the session at $122.36, with a gain of 0.49% or 0.6 points. The heightened volatility saw the trading volume jump to 12,97,449 shares. Company has a market cap of $45,760 M.

On the company’s financial health, Stryker Corporation reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Apr 20, 2016. Analyst had a consensus of $1.20. The company had revenue of $2495.00 million for the quarter, compared to analysts expectations of $2471.86 million. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS.

Many Wall Street Analysts have commented on Stryker Corporation. Stryker Corporation was Initiated by Guggenheim to “Buy” on Jun 9, 2016. Stryker Corporation was Upgraded by Sterne Agee CRT to ” Buy” on Apr 27, 2016. Company shares were Reiterated by RBC Capital Mkts on Apr 26, 2016 to “Outperform”, Firm has raised the Price Target to $ 120 from a previous price target of $108 .

Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Stryker Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Stryker Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.